Patient engagement through advisory boards, surveys, and listening sessions can help address industry challenges like trial ...

In order to learn more about patients and allow public input, the FDA conducted 24 disease-specific Patient-Focused Drug Development (PFDD) meetings to systematically gather patients ...

In the United States, learning how to navigate forums such as the FDA’s listening sessions and patient-focused drug development (PFDD) meetings could be the key to “truly moving the dial”.